Latest International Stem Cell Corporation Stories

2011-04-19 07:00:00

DALLAS, April 19, 2011 /PRNewswire/ -- Click Here, Inc., and Richards Partners have been selected as agencies of record by Lifeline Skin Care(TM), a wholly owned subsidiary of International Stem Cell Corporation (OTCBB: ISCO), a California-based biotechnology company focused on therapeutic and research products. Lifeline offers luxury anti-aging skin care products developed using its proprietary stem cell technology. Based in Dallas and part of The Richards Group - the nation's largest...

2008-10-16 09:00:42

International Stem Cell Corporation (OTCBB:ISCO) (www.internationalstemcell.com), a California-based, early-stage stem cell therapeutics company, announced today that Rouslan Semechkin has joined its Board of Directors. International Stem Cell Corporation's focus is on the development of stem cell based treatment of diabetes, liver disease and diseases of the retina and providing specialized cells and media to others for cell based research. It maintains corporate and research facilities...

2008-08-21 09:01:14

International Stem Cell Corporation (OTCBB: ISCO) has entered into a subscription agreement with an accredited investor to sell three million dollars ($3,000,000) of Series C Preferred Stock at a price of $1.00 per share. The funding is to occur in three tranches. The first, for $700,000, closed August 20, 2008. The second closing for $1,300,000 is scheduled for September 23, 2008 and the final closing of $1,000,000 is scheduled for December 15, 2008, subject to determination by the investor...

2008-07-17 09:01:20

International Stem Cell Corporation (OTCBB:ISCO) announced today a collaboration with Novocell Inc. (La Jolla, CA) to use ISCO's human parthenogenetic stem cell lines for differentiation to Human pancreatic islet cells. The studies will be directed by Nikolay Turovets, PhD, Director, Research and Therapeutic Development at ISCO in collaboration with Novocell scientists. ISCO's unique stem cells offer a solution for two of the most difficult problems facing stem cell therapy. They are the...

2008-07-08 06:00:36

International Stem Cell Corporation (OTCBB: ISCO) announced today a new collaboration with leading stem cell researcher Jose Cibelli at Michigan State University as part of ISCO's ongoing strategy to work with scientific leaders across the world to expand the scientific data relating to parthenogenetic stem cells. Professor Cibelli will study gene expression in several human parthenogenetic stem cell lines and compare the results with fertilized embryonic stem cells. According to...

2008-06-25 09:03:33

International Stem Cell Corporation (OTCBB:ISCO), through its wholly owned subsidiary Lifeline Cell Technology (Lifeline), has signed a manufacturing and distribution agreement with BioTime, Inc., (OTCBB:BTIM) (Alameda, CA) and BioTime's wholly owned subsidiary Embryome Sciences, Inc., to jointly produce and distribute hundreds of new standardized human and animal stem cell lines, along with corresponding data and reagents. The mutual goal is to provide the "picks and shovels" for scientists...

Word of the Day
  • Good cheer; viands.
  • To revel; to feast.
The word 'bellycheer' may come from 'belle cheer', "good cheer".